InVivoMab anti-mouse LAG-3 / L

【第98期】前沿靶点速递 | LAG3、FGF21、HSF1等9项重磅研究进展

01 靶点：LAG3   应用：复发胶质母细胞瘤的潜在治疗靶点来源：Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.Nat Med, 2026 Jul Michael Lim团队在Nature Medicine上发表了一项关于复发胶质母细胞瘤免疫治疗的研究。该研究依托美国成人脑肿瘤联盟开展I期临床试验，首次系统评估了抗LAG-3单抗relatlimab单药

Immunocytochemistry Protocol Using Anti-GFP Antibodies(使用抗GFP抗体的免疫细胞化学实验方案)

实验试剂   X Dulbecco’s Phosphate-buffered saline (D-PBS) Fixative solution: 4% Formaldehyde solution in PBS, pH 7.4 Permeabilizing solution: 0.25% Triton® X-100 in PBS, pH 7.4 Blocking solution: 5% Normal Goat

抗原、抗体标准品

; 0.78 IU / ampoule VWF: ristocetin cofactor; 0.94 IU / ampoule VWF: collagen binding 人凝血因子VIII原液冻干粉 11.0 IU /ampoule. 人凝血因子II, VII, IX, X血浆冻干粉 0.91 IU / (factor II), 1.00 IU (factor VII), 0.86IU (factor IX), 0.93 IU(factor X) / ampoule 人凝血因子II, and, X